[The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008357:Mannomustine / Q000009:adverse effects; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010710:Phosphates / Q000009:adverse effects; D010720:Phosphines / Q000009:adverse effects; D013274:Stomach Neoplasms / Q000188:drug therapy; D013852:Thiotepa / Q000009:adverse effects; D014498:Uracil / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D010710:Phosphates; D010720:Phosphines; D014498:Uracil; D013852:Thiotepa; D008357:Mannomustine
Gipoplasticheskoe sostoianie krovetvoreniia posle khimioterapii alkiliruiushchimi soedineniiami.